SCHEMBL25580869

SCHEMBL25580869

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2cccc(N(c3cccc4ccccc34)c3cccc4c3oc3ccccc34)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.39
▸ GGPS1 O95749 1/20 0.35
▸ PTGES2 Q9H7Z7 1/20 0.33
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ PRKDC P78527 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ MAOB P27338 1/20 0.31
▸ SIGMAR1 Q99720 1/20 0.30
▸ F2 P00734 1/20 0.30
▸ F10 P00742 1/20 0.30
▸ PLG P00747 1/20 0.30
▸ PLAU P00749 1/20 0.30
▸ PLAT P00750 1/20 0.30
▸ PRSS1 P07477 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580173 0.93 ALOX5 (0.37) ALOX5GGPS1PTGES2CYP1A1CYP1A2
SCHEMBL25578933 0.93 ALOX5 (0.39) ALOX5GGPS1PTGES2CYP1A1CYP1A2
SCHEMBL25579308 0.93 ALOX5 (0.44) ALOX5GGPS1PTGES2CYP1A1CYP1A2
SCHEMBL25580845 0.92 ALOX5 (0.41) ALOX5GGPS1PTGES2CYP1B1PRKDC
SCHEMBL25580572 0.91 ALOX5 (0.38) ALOX5GGPS1PTGES2PRKDCKDM4E
SCHEMBL25580980 0.91 ALOX5 (0.42) ALOX5GGPS1PTGES2CYP1B1PRKDC
SCHEMBL25580480 0.91 ALOX5 (0.40) ALOX5GGPS1PTGES2CYP1A1CYP1A2
SCHEMBL25581005 0.91 ALOX5 (0.40) ALOX5GGPS1PTGES2CYP1A1CYP1A2
SCHEMBL25580879 0.91 ALOX5 (0.45) ALOX5GGPS1PTGES2CYP1A1CYP1A2
SCHEMBL25580956 0.90 ALOX5 (0.43) ALOX5GGPS1PTGES2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 ALOX5 1615/4885GGPS1 4169/4885PTGES2 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback